33 related articles for article (PubMed ID: 27548508)
1. Aptamer-functionalized liposomes for drug delivery.
Wong KY; Wong MS; Liu J
Biomed J; 2023 Dec; ():100685. PubMed ID: 38081386
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-Functionalized Liposomes as a Potential Treatment for Basal Cell Carcinoma.
Cadinoiu AN; Rata DM; Atanase LI; Daraba OM; Gherghel D; Vochita G; Popa M
Polymers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540426
[TBL] [Abstract][Full Text] [Related]
3. Nuclear pore complexes as hubs for gene regulation.
D'Angelo MA
Nucleus; 2018 Jan; 9(1):142-148. PubMed ID: 29095096
[TBL] [Abstract][Full Text] [Related]
4. A short linear motif in scaffold Nup145C connects Y-complex with pre-assembled outer ring Nup82 complex.
Teimer R; Kosinski J; von Appen A; Beck M; Hurt E
Nat Commun; 2017 Oct; 8(1):1107. PubMed ID: 29062044
[TBL] [Abstract][Full Text] [Related]
5. Natively Unfolded FG Repeats Stabilize the Structure of the Nuclear Pore Complex.
Onischenko E; Tang JH; Andersen KR; Knockenhauer KE; Vallotton P; Derrer CP; Kralt A; Mugler CF; Chan LY; Schwartz TU; Weis K
Cell; 2017 Nov; 171(4):904-917.e19. PubMed ID: 29033133
[TBL] [Abstract][Full Text] [Related]
6. A self-inhibitory interaction within Nup155 and membrane binding are required for nuclear pore complex formation.
De Magistris P; Tatarek-Nossol M; Dewor M; Antonin W
J Cell Sci; 2018 Jan; 131(1):. PubMed ID: 29150488
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of nuclear pore complex assembly - two different ways of building one molecular machine.
Otsuka S; Ellenberg J
FEBS Lett; 2018 Feb; 592(4):475-488. PubMed ID: 29119545
[TBL] [Abstract][Full Text] [Related]
8. Nuclear pore complex plasticity during developmental process as revealed by super-resolution microscopy.
Sellés J; Penrad-Mobayed M; Guillaume C; Fuger A; Auvray L; Faklaris O; Montel F
Sci Rep; 2017 Nov; 7(1):14732. PubMed ID: 29116248
[TBL] [Abstract][Full Text] [Related]
9. Getting mRNA-Containing Ribonucleoprotein Granules Out of a Nuclear Back Door.
Parchure A; Munson M; Budnik V
Neuron; 2017 Nov; 96(3):604-615. PubMed ID: 29096075
[TBL] [Abstract][Full Text] [Related]
10. Targeting Insulin Receptor with a Novel Internalizing Aptamer.
Iaboni M; Fontanella R; Rienzo A; Capuozzo M; Nuzzo S; Santamaria G; Catuogno S; Condorelli G; de Franciscis V; Esposito CL
Mol Ther Nucleic Acids; 2016 Sep; 5(9):e365. PubMed ID: 27648925
[TBL] [Abstract][Full Text] [Related]
11. Cabazitaxel liposomes with aptamer modification enhance tumor‑targeting efficacy in nude mice.
Cheng Y; Ou Z; Li Q; Yang J; Hu M; Zhou Y; Zhuang X; Zhang ZJ; Guan S
Mol Med Rep; 2019 Jan; 19(1):490-498. PubMed ID: 30483775
[TBL] [Abstract][Full Text] [Related]
12. Construction of an aptamer modified liposomal system targeted to tumor endothelial cells.
Ara MN; Matsuda T; Hyodo M; Sakurai Y; Ohga N; Hida K; Harashima H
Biol Pharm Bull; 2014; 37(11):1742-9. PubMed ID: 25366480
[TBL] [Abstract][Full Text] [Related]
13. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
14. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances in the study of cleavable PEG-lipid derivatives modifying liposomes].
Xu H; Deng YH; Chen DW
Yao Xue Xue Bao; 2008 Jan; 43(1):18-22. PubMed ID: 18357726
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Nucleoporin358-Specific RNA Aptamer for Use as a Nucleus-Targeting Liposomal Delivery System.
Shrivastava G; Hyodo M; Yoshimura SH; Akita H; Harashima H
Nucleic Acid Ther; 2016 Oct; 26(5):286-298. PubMed ID: 27548508
[TBL] [Abstract][Full Text] [Related]
17. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
